IFF to Showcase Science-backed Low Nitrite Excipients at Excipient World 2024
IFF to Showcase Science-backed Low Nitrite Excipients at Excipient World 2024
PR Newswire
NEW YORK, April 29, 2024
Experts will present risk assessment strategies for nitrite detection and quality evaluation to promote safer pharmaceutical formulations with better patient outcomes
NEW YORK, April 29, 2024 /PRNewswire/ -- IFF's Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15, Gaylord Palms Resort and Convention Center, Kissimmee, Florida at booth 214.
Nitrosamine risk assessment and control have become an integral part of pharmaceutical drug product development and quality evaluation. With more than 70 years of expertise in cellulosic excipients, IFF's pioneering, leading brands ─ Avicel® PH LN, a robust low nitrite microcrystalline cellulose (MCC) and METHOCEL™ range of water-soluble cellulose ethers are proven effective in reducing nitrosamines in model formulations.
"As the pharmaceutical landscape evolves, it is important to address and solve any challenges associated with nitrosamine risk," said Angela Strzelecki, president, Pharma Solutions, IFF. "Collaborating with an excipient manufacturer with vital expertise, and robust formulation and analytical capabilities enables drug developers to confidently and efficiently incorporate low nitrite excipients into their formulations."
Attendees will have the opportunity to meet with IFF experts and discuss areas such as regulatory compliance, quality, consistency, product innovation, and how the Company's state-of-the-art excipients can help elevate drug formulations, optimize drug delivery, and ultimately contribute to patient well-being.
IFF will share nitrosamine analytical insights and the latest scientific advancements during the following informative sessions:
- On May 14, 11.15 a.m.–12.00 p.m. ET, Sun Ballroom, Stage 2, Koudi Zhu, analytical scientist, Pharma Solutions will present on nitrite detection and ensuring safer pharmaceutical formulations, titled "Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients".
- From May 13-15, Priscilla Zawislak, IFF senior manager, Scientific and Public Affairs, and past chair of IPEC-Americas, will present the importance and role of excipients in oral drug delivery, and regulatory and quality considerations relating to excipients at the Excipients 101 workshop and other educational sessions.
Register here to schedule a meeting at Excipient World 2024.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partner with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Contact:
Lisa Luke
Global Communications Director
1 302-927-9234
Lisa.Luke@iff.com
SOURCE IFF
-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now